- Asthma Center
- Allergy & Immunology
- Childhood Cancer
- Childrens Express Care
- Ear, Nose & Throat (ENT)
- Emergency Medicine
- Infectious Diseases
- Medical Genetics
- Newborn Medicine
- Primary Care
- Transplant Programs
- International Services
- Health Info Management
- Poison Control Center
- Ronald McDonald House
- Social Work
- Telemedicine Program
- Volunteer Services
Patients and Families
Planning a Visit
- Get Directions
- Childrens Locations
- Getting Around
- Guidelines for Visitors
- Contact a Patient
- Contact Children's
- Send an e-Card
- Gift Shop
- Find a Doctor
- Child Health A-Z
- Community Ed.Classes
- Injury Prevention
- International Patients
- Medical Records
- Patient Handbook
- Patient Procedures
- Safety Center
- Adolescent Medicine
- Babysitting Class
- Diseases & Conditions
- Drugs and Alcohol
- Injury Prevention
- Schools & Jobs
- Sexual Health
- Teen Health
- For Health Professionals
- Ways to Give
- Rebooting Cell Programming Can Reverse Liver Failure
- New Center Offers Hope to Kids From Around the World With Rare Diseases
- Free Care Fund Benefit Show Raises More Than $2.1 Million
For Immediate Release
Children's Hospital of Pittsburgh Receives Congressional Recognition as the Leader in Pediatric Transplantation for 25 years
From Thomas Starzl, MD, to George Mazariegos, MD, - Children's Hillman Center for Pediatric Transplantation continues to pioneer approaches to improve outcomes and quality of life for children
Pittsburgh, Pa. - June 2, 2006 -
Children's Hospital of Pittsburgh has received congressional recognition as the world's premiere center for pediatric transplantation for the past 25 years, longer than any other center in the world.
Introduced by Congressman Mike Doyle (D-PA), the acknowledgment was officially made a part of the congressional record last week, commemorating Children's for 25 years of service and for the establishment of the nation's first pediatric transplantation center.
In the 25 years since establishing the first pediatric transplant center under the guidance of transplant pioneer Thomas E. Starzl, MD, PhD, Children's Hillman Center for Pediatric Transplantation has performed more than 2,200 transplant and today is a leader in developing strategies to manage organ rejection. Transplant surgeons offer a regimen of anti-rejection drugs that not only protects the transplanted organ, but in many cases allows surgeons to wean young patients from steroids soon after surgery.
"Doctors and researchers in Pittsburgh have continued to dedicate their life's work to helping advance pediatric transplantation. Over the years, surgeons have improved surgical techniques and recovery strategies to offer children far-reaching opportunities for long-term survival with a strong quality of life," said George Mazariegos, MD, director, Pediatric Transplantation at Children's.
From the first and most successful series of small intestine transplants to the landmark work of challenging pediatric multi-organ transplants, Children's continually achieves milestones in the operating room and laboratory.
As one of the leading pediatric transplant centers in the world, Children's performs more kinds of organ and tissue transplants in children than does any other center in the United States - including heart, heart/lung, heart/liver, lung, double-lung, liver, split-liver, living-related liver, heart/lung/liver, liver/kidney, liver/small intestine, kidney, living-related kidney/bone marrow, intestine, pancreas, multivisceral and bone marrow.
Father of Organ Transplantation
Dr. Starzl is known as the father of organ transplantation and a thinker who remains well ahead of his time. More than 40 years ago, he pioneered an entirely new field of medicine and, over the course of his career, turned an intriguing research concept into an accepted medical practice that has given, and continues to give, hope to thousands who previously had none.
Pittsburgh witnessed and celebrated medical firsts: the first multiple organ transplant in 1983; the first heart and liver transplant in 1984; the first liver and intestine transplant in 1990.
This year, Dr. Starzl was awarded the National Medal of Science, the nation's highest scientific honor.
Research programs at Children's are helping to advance pediatric transplantation. Important clinical trials in research include progress in immunotherapy, transplantation tolerance, organ preservation, bioengineering, living intestine transplants and post-transplant therapies, including the reduction of steroid-based and immunosuppressive drugs.
Dr. Mazariegos and his colleagues have successfully weaned liver transplant patients off potentially toxic immunosuppressive medications without the use of steroids, which for decades have been used worldwide as standard treatment to prevent rejection following transplant surgery. Furthermore, Dr. Mazariegos and colleague Rakesh Sindhi, MD, are developing blood tests that would help surgeons determine when a patient could be weaned from immunosuppression and also is coordinating the development of an artificial liver support system for children in liver failure.
In addition to clinical trials in research, Children's is in the forefront of the monitoring of infectious disease - and preventing such disease from developing into critical problems.
Children's Hospital of Pittsburgh - Leader in Pediatric Transplantation - has:
- performed the world's first pediatric double-lung transplant.
- performed the world's first pediatric heart-lung transplant.
- performed the world's first pediatric heart-liver transplant.
- has also been one of the only pediatric transplant centers in the world to pioneer the use of a ventricular assist device as a bridge to heart transplantation.
- has performed more pediatric heart-lung transplants than any other center in the country.
- has the most active pediatric liver transplant center in the country.
- has performed more pediatric intestinal transplants than any other center in the country.
1 year: Children's 98%; National average 90%
3 years: Children's 91%; National average 85%
2 years: Children's 91%; National average 70% (international)
4 years: Children's 89%; National average 77%
8 years: Children's 83%; National average 68%
Children's - no mortalities in prior 4 years; National average 69% at 3 years
3 years: Children's 100%; National average 98%
Children's 91-97% (depending on type); National average 70-90%
June 17, 2008
June 17, 2008